This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)
Clinical trial NCT03604445 · TERMINATED
Trial details
- NCT number
- NCT03604445
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2022-07-27
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.